Bioequivalence and Bioavailability Forum

sample size for clini­cal endpoint BE study of Brinzol­amide 1% ophthal­mic [Design Issues]

posted by kishpokuri – India, 2015-11-24 15:18 (3866 d 00:07 ago) – Posting: # 15665
Views: 8,171

Hi all,
Can anyone suggest the appropriate sample size for a clinical endpoint bioequivalence study of Brinzolamide 1% ophthalmic suspension in chronic open angle glaucoma patients.
OGD guidelines has not mentioned regarding this.
Thank you,
Regards,
Dr. Kishan PV

---

Edit: Category changed. [Helmut]

Complete thread:

• sample size for clini­cal endpoint BE study of Brinzol­amide 1% ophthal­mickishpokuri 2015-11-24 14:18 
  • general remark ElMaestro 2015-11-24 16:50
  • Specific remarks d_labes 2015-11-25 11:23
    • Specific remarks kishpokuri 2015-11-27 13:46